|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent BHVN insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why BHVN insider buys are important for investors to follow.
Date | Insider | Price | Amount |
4-22-2024 Insider Buy |
Vlad Coric Chief Executive Officer |
$41.00
CAGR »
|
$4,999,991.00 121,951 shares |
4-22-2024 Insider Buy |
John W. Childs
|
$41.00
CAGR »
|
$7,999,961.00 195,121 shares |
4-22-2024 Insider Buy |
Gregory Bailey
|
$41.00
CAGR »
|
$1,999,980.00 48,780 shares |
8-19-2022 Insider Buy |
Gregory Bailey
|
$148.04
CAGR »
|
$5,625,675.80 38,000 shares |
10-5-2023 Insider Buy |
John W. Childs
|
$22.00
CAGR »
|
$9,999,990.00 454,545 shares |
10-5-2023 Insider Buy |
Vlad Coric Chief Executive Officer |
$22.00
CAGR »
|
$9,999,990.00 454,545 shares |
10-4-2023 Insider Buy |
Gregory Bailey
|
$22.57
CAGR »
|
$402,094.06 17,817 shares |
10-5-2023 Insider Buy |
Matthew Buten Chief Financial Officer |
$22.00
CAGR »
|
$499,994.00 22,727 shares |
8-30-2023 Insider Buy |
John W. Childs
|
$18.44
CAGR »
|
$922,180.00 50,000 shares |
8-4-2023 Insider Buy |
John W. Childs
|
$19.78
CAGR »
|
$1,978,430.00 100,000 shares |
10-25-2022 Insider Buy |
John W. Childs
|
$10.50
CAGR »
|
$38,953,099.50 3,709,819 shares |
10-31-2022 Insider Buy |
Vlad Coric Chief Executive Officer |
$15.97
CAGR »
|
$411,995.04 25,800 shares |
10-28-2022 Insider Buy |
Vlad Coric Chief Executive Officer |
$14.84
CAGR »
|
$2,105,772.35 141,930 shares |
10-25-2022 Insider Buy |
Julia P. Gregory
|
$10.50
CAGR »
|
$99,991.50 9,523 shares |
10-25-2022 Insider Buy |
Matthew Buten Chief Financial Officer |
$10.50
CAGR »
|
$1,499,998.50 142,857 shares |
10-25-2022 Insider Buy |
Vlad Coric Chief Executive Officer |
$10.50
CAGR »
|
$8,960,490.00 853,380 shares |
10-25-2022 Insider Buy |
Gregory Bailey
|
$10.50
CAGR »
|
$2,100,000.00 200,000 shares |
8-19-2022 Insider Buy |
Gregory Bailey
|
$148.04
CAGR »
|
$5,625,675.80 38,000 shares |
3-17-2021 Insider Buy |
John W. Childs
|
$76.00
CAGR »
|
$999,932.00 13,157 shares |
3-2-2021 Insider Buy |
John W. Childs
|
$85.14
CAGR »
|
$851,370.00 10,000 shares |
11-23-2020 Insider Buy |
John W. Childs
|
$89.55
CAGR »
|
$447,736.50 5,000 shares |
9-21-2020 Insider Buy |
John W. Childs
|
$59.25
CAGR »
|
$196,828.50 3,322 shares |
9-11-2020 Insider Buy |
John W. Childs
|
$59.00
CAGR »
|
$393,983.97 6,678 shares |
8-11-2020 Insider Buy |
John W. Childs
|
$61.54
CAGR »
|
$1,538,484.81 25,000 shares |
8-20-2019 Insider Buy |
Gregory Bailey Director |
$37.65
CAGR »
|
$188,250.00 5,000 shares |
6-27-2019 Insider Buy |
Robert Berman Chief Medical Officer |
$42.30
CAGR »
|
$105,750.00 2,500 shares |
6-27-2019 Insider Buy |
James Engelhart Chief Financial Officer |
$43.05
CAGR »
|
$107,625.00 2,500 shares |
6-26-2019 Insider Buy |
John W. Childs Director |
$40.37
CAGR »
|
$403,700.00 10,000 shares |
5-9-2017 Insider Buy |
Gregory Bailey Director |
$17.00
CAGR »
|
$2,975,000.00 175,000 shares |
5-9-2017 Insider Buy |
Albert Cha Director |
$17.00
CAGR »
|
$7,990,000.00 470,000 shares |
5-9-2017 Insider Buy |
John W. Childs Director and >10% Owner |
$17.00
CAGR »
|
$7,055,000.00 415,000 shares |
Also See: Institutional Holders of BHVN
Also See: SEC filings
Below we present the annualized performance delivered by BHVN stock since 4-22-2024 (the date of the most recent
insider purchase). The performance of the investment from the time BHVN insider buying occurred is the ultimate
test of whether insiders were right about BHVN being a good buy.
Because the insider purchase was so recent, we don't have a meaningful CAGR result yet; please check back at a later date or use the calculator to examine CAGR over other time periods.
BHVN Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent BHVN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding BHVN
|
|